References
- Bechtel, Y. C., Bonaiti-Pellie, C., Poisson, N., Magnette, J. N. and Bechtel, P. R. (1993) A population and family study of N-acetyltransferase using caffeine urinary metabolites. Clin. Pharmacol. Ther. 54, 134-141. https://doi.org/10.1038/clpt.1993.124
- Bista, S. R., Lee, S. K., Thapa, D., Kang, M. J., Seo, Y. M., Kim, J. H., Kim, D. H., Jahng, Y., Kim, J. A. and Jeong, T. C. (2008) Effects of oral rutaecarpine on the pharmacokinetics of intravenous chlorzoxazone in rats. Toxicol. Res. 24, 195-199. https://doi.org/10.5487/TR.2008.24.3.195
-
Caubet, M. S., Comte, B. and Brazier. J. L. (2004) Determination of urinary
$^{13}C$ -caffeine metabolites by liquid chromatography-mass spectrometry: the use of metabolic ratios to assess CYP1A2 activity. J. Pharmaceut. Biomed. Anal. 34, 379-389. https://doi.org/10.1016/S0731-7085(03)00528-4 - Chen, L., Bondoc, F. Y., Lee, M. J., Hussin. A. H., Thomas. P. E. and Yang. C. S. (1996) Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats. Drug Metab. Dispos. 24, 529-533.
- Chiou, W. F., Liao, J. P. and Chen, C. F. (1996) Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J. Nat. Prod. 59, 374-378. https://doi.org/10.1021/np960161+
- Chiou, W. L. (1978) Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level - time curve. J. Pharmacokinet. Biopharm. 6, 539-546. https://doi.org/10.1007/BF01062108
- Jan, W. C., Lin, L. C, Chen, C. F. and Tsai, T. H. (2005) Herb-drug interaction of Evodia rutaecarpa extract on the pharmacokinetics of theophylline in rats. J. Ethnopharmacol. 102, 440-445. https://doi.org/10.1016/j.jep.2005.07.002
- Lee, S. H., Kim, S. I., Park, J. G., Lee, E. S., and Jahng, Y. (2001) A simple synthesis of rutaecarpine. Heterocycles 55, 1555-1559. https://doi.org/10.3987/COM-01-9244
- Lee, S. K., Bista, S. R., Jeong, H. M., Kim, D. H., Kang, M. J., Jahng, Y. and Jeong, T. C. (2007) The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats. Arch. Pharm. Res. 30, 1629-1634. https://doi.org/10.1007/BF02977334
- Lee, S. K., Kim, N. H., Lee, J., Kim, D. H., Lee, E. S., Choi, H. G., Chang, H. W., Jahng, Y. and Jeong, T. C. (2004a) Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s. Planta Med. 70, 753-757. https://doi.org/10.1055/s-2004-827207
- Lee, S. K., Lee, D. W., Jeon, T. W., Jin, C. H., Kim, G. H., Jun, I. H., Lee, D. J., Kim, S. I., Kim, D. H., Jahng, Y. and Jeong, T. C. (2005) Characterization of the phase 2 metabolites of rutaecarpine in rats by liquid chromatography-electrospray ionization-tandem mass spectrometry. Xenobiotica 35, 1135-1145. https://doi.org/10.1080/00498250500363742
- Lee, S. K., Lee, J., Lee, E. S., Jahng, Y., Kim, D. H. and Jeong, T. C. (2004b) Characterization of in vitro metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 18, 1073-1080. https://doi.org/10.1002/rcm.1448
- Lee, S. K., Lee, J. H., Yoo, H. H., Kim, D. H., Jahng, Y. and Jeong, T. C. (2006) Characterization of human liver cytochrome P450 enzymes involved in the metabolism of rutaecarpine. J. Pharm. Biomed. Anal. 41, 304-309. https://doi.org/10.1016/j.jpba.2005.10.039
- Moon, T. C., Murakami, M., Kudo, I., Son, K. H., Kang, S. S. and Chang, H. W. (1999) A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa. Inflamm. Res. 48, 621-625. https://doi.org/10.1007/s000110050512
- Noh, K., Seo, Y. M., Lee, S. K., Bista, S. R., Kang, M. J., Jahng, Y., Kim, E., Kang, W. and Jeong, T. C. (2011) Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats. Arch. Pharm. Res. 34, 119-125. https://doi.org/10.1007/s12272-011-0114-3
- Tsai, T. H., Chang, C. H. and Lin, L. C. (2005) Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats. Planta Med. 71, 640-645. https://doi.org/10.1055/s-2005-871270
- Ueng, Y. F., Don, M. J., Peng, H. C., Wang, S. Y., Wang, J. J., and Chen, C. F. (2002a) Effects of Wu-chu-yu-tang and its compound herbs on drug-metabolizing enzymes. Jpn. J. Pharmacol. 89, 267-272. https://doi.org/10.1254/jjp.89.267
- Ueng, Y. F., Jan, W. C., Lin, L. C., Chen, T. L., Guengerich, F. P. and Chen, C. F. (2002b)The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Drug Metab. Dispos. 30, 349-353. https://doi.org/10.1124/dmd.30.3.349
- Ueng, Y. F., Tasi, T. H, Don, M. J., Chen, R. M. and Chen, T. L. (2005) Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats. J. Pharm. Pharmacol. 57, 227-232. https://doi.org/10.1211/0022357055489
- Ueng, Y. F., Wang, J. J., Lin, L. C., Park, S. S., and Chen, C. F. (2001) Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa. Life Sci. 70, 207-217. https://doi.org/10.1016/S0024-3205(01)01390-X
- Woo, H. G., Lee, C. H., Noh, M. S., Lee, J. J., Jung, Y. S., Baik, E. J., Moon, C. H. and Lee, S. H. (2001) Rutaecarpine, a quinazolinocarboline alkaloid, inhibits prostaglandin production in RAW264.7 macrophages. Planta Med. 67, 505-509. https://doi.org/10.1055/s-2001-16479
- Yuan, R., Madani, S., Wei, X. X., Reynolds, K. and Huang, S. M. (2002) Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab. Dispos. 30, 1311-1319. https://doi.org/10.1124/dmd.30.12.1311